首页> 外文OA文献 >Pro-coagulant haemostatic factors for the prevention and treatment of bleeding in people without haemophilia

【2h】

Pro-coagulant haemostatic factors for the prevention and treatment of bleeding in people without haemophilia

机译：促凝血剂的止血因子，用于预防和治疗人们在没有血友病的情况下出血

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Jez Fabes; Susan J Brunskill; Nicola Curry; Carolyn Doree; Simon J Stanworth;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. The potential correlation between patient-reported symptoms and the use of additional haemostatic medication for joint bleeding in haemophilia patients with inhibitors: a post hoc exploratory analysis of recombinant activated factor VII data from the ADEPT2 trial [J] . Lentz Steven R., Rangarajan Savita, Karim Faraizah A., Blood coagulation & fibrinolysis: an international journal in haemostasis and thrombosis . 2017,第3期

机译：患者报告的症状与额外血液化药物在血友病患者患者中使用额外的血液化药物的潜在相关性：来自ADEPT2试验的重组活性因子VII数据的后HOC探索性分析
2. Obesity in haemophilia patients: Effect on bleeding frequency, clotting factor concentrate usage, and haemostatic and fibrinolytic parameters [J] . TuinenburgA., Biere-RafiS., PetersM., Haemophilia: the official journal of the World Federation of Hemophilia . 2013,第5期

机译：血友病患者的肥胖：对出血频率，凝血因子浓缩剂的使用以及止血和纤溶参数的影响
3. Recombinant activated factor VII in the treatment of bleeds and for the prevention of surgery-related bleeding in congenital haemophilia with inhibitors [J] . Santagostino Elena, Escobar Miguel, Ozelo Margareth, Blood reviews . 2015,第Suppla1期

机译：重组活化因子VII与抑制剂一起治疗先天性血友病的出血和预防与手术有关的出血
4. Why Are There People With Psychosis And People Without? Is It All Due To Genetic And Vulnerability Factors [C] . Edo S. Jaya International Conference of Intervention and Applied Psychology . 2018

机译：为什么有精神病和人的人没有？这是由于遗传和脆弱因素
5. Combined deficiency of factors V and VIII by chance coinheritance of parahaemophilia and haemophilia A, but not by mutations of either LMAN1 or MCFD2 [D] . 鈴木幸子 2019

机译：副血友病和A血友病的偶然一致性导致因子V和VIII的联合缺乏，但不是LMAN1或MCFD2的突变
6. The potential correlation between patient-reported symptoms and the use of additional haemostatic medication for joint bleeding in haemophilia patients with inhibitors: a post hoc exploratory analysis of recombinant activated factor VII data from the ADEPT2 trial [O] . Steven R. Lentz, Savita Rangarajan, Faraizah A. Karim, -1

机译：患者报告的症状与使用带抑制剂的血友病患者关节出血使用其他止血药之间的潜在相关性：ADEPT2试验中重组活化因子VII数据的事后探索性分析
7. Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia [O] . Simpson, E, Lin, Y, Stanworth, Simon, 2013

机译：重组因子VIIa用于预防和治疗无血友病患者的出血

Pro-coagulant haemostatic factors for the prevention and treatment of bleeding in people without haemophilia

著录项

引文网络

相似文献

相关主题

期刊订阅